Role of liposome type and route of administration in the antitumor activity of liposome-entrapped 1-beta-D-arabinofuranosylcytosine against mouse L1210 leukemia.
D000284:Administration, Oral; D000818:Animals; D003561:Cytarabine / Q000008:administration & dosage* / Q000633:toxicity; D005260:Female; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D007928:Lethal Dose 50; D007939:Leukemia L1210 / Q000188:drug therapy*; D008081:Liposomes; D051379:Mice; D008811:Mice, Inbred DBA
D008081:Liposomes; D003561:Cytarabine